Segall Bryant & Hamill’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,000	Closed	-$380K	–	516
2023 Q2	$380K	Hold	2,000	–	–	﹤0.01%	606
2023 Q1	$400K	Hold	2,000	–	–	﹤0.01%	601
2022 Q4	$475K	Hold	2,000	–	–	0.01%	579
2022 Q3	$400K	Hold	2,000	–	–	﹤0.01%	611
2022 Q2	$292K	Hold	2,000	–	–	﹤0.01%	664
2022 Q1	$327K	Hold	2,000	–	–	﹤0.01%	668
2021 Q4	$339K	Hold	2,000	–	–	﹤0.01%	539
2021 Q3	$378K	Hold	2,000	–	–	﹤0.01%	665
2021 Q2	$339K	Sell	2,000 -9	-0.4%	-$1.32K	﹤0.01%	673
2021 Q1	$283K	Hold	2,009	–	–	﹤0.01%	737
2020 Q4	$261K	Hold	2,009	–	–	﹤0.01%	672
2020 Q3	$292K	Buy	2,009 +9	+0.5%	+$1.28K	﹤0.01%	625
2020 Q2	$296K	Hold	2,000	–	–	0.01%	683
2020 Q1	$218K	Hold	2,000	–	–	﹤0.01%	728
2019 Q4	$230K	Buy	+2,000	New	+$199K	﹤0.01%	773
2018 Q2	–	Sell	-2,000	Closed	-$238K	–	854
2018 Q1	$238K	Hold	2,000	–	–	0.01%	562
2017 Q4	$254K	Hold	2,000	–	–	0.01%	520
2017 Q3	$235K	Buy	+2,000	New	+$171K	0.01%	530
2015 Q3	–	Sell	-2,000	Closed	-$240K	–	544
2015 Q2	$240K	Hold	2,000	–	–	0.01%	510
2015 Q1	$209K	Buy	+2,000	New	+$203K	﹤0.01%	533